|« Previous month||Next month »|
29-Nov-2012 - Pharmaceutical sponsors are not doing enough to ensure the CROs they work with conduct trials safely and ethically, according to a new report.
29-Nov-2012 - The group behind the excipient certification scheme Excipact will train SGS and blue inspection body GmbH auditors under agreements signed this week.
28-Nov-2012 - Selecta Biosciences will provide Sanofi with discovery services in a deal that could be worth up to $900m.
28-Nov-2012 - No job cuts or facility divestitures are planned at SAFC under reorganisation announced by parent company Sigma-Aldrich.
28-Nov-2012 - Post-approval service providers must collect less but more focussed data for successful drug launches, according to INC Research.
27-Nov-2012 - The bioavailability market lacks a leader that can offer comprehensive solutions according to Merck Millipore, which has set its sights on filling the gap with new lab.
27-Nov-2012 - Pfizer is re-jigging its failed virtual trial model and could re-launch the programme as soon as 2013.
27-Nov-2012 - The Indian Government will stamp out “fly by night operators” in its clinical trials sector by plugging "loopholes" in the regulations.
26-Nov-2012 - Risk-based monitoring means certain aspects of clinical trials can be quality checked using a segment of the data, according to Annex Clinical.
26-Nov-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest movers and shakers in the world of pharmaceutical outsourcing, including news from Onyx, Pacific Biomarker and Rx&D.
22-Nov-2012 - The US FDA wants IRBs to remember it is their responsibility to check investigator qualifications, make sure sites are up to code and say if an IND is necessary for...
22-Nov-2012 - Single-use technology will see more HP production brought in-house but contract manufacturers will still win-out, according to Alkermes.
22-Nov-2012 - Sigma-Aldrich has announced a plan to realign its business operations along regional and customer-focused lines.
22-Nov-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest career climbers including news from CTI, AndersonBrecon and CIS.
21-Nov-2012 - High CRA turnover in China often hinders trials, according to an Oxford University expert.
21-Nov-2012 - Outsourcing-pharma.com readers want the acronym CRO to stand for 'contract research organisation' according to the results of a snap poll we ran yesterday.
21-Nov-2012 - Catalent will cut 45 staff from its Swindon facility after customers reduce Zydis order volumes.
21-Nov-2012 - CRO QPS has added another 24 beds to its Phase I site in the Netherlands, citing increasing demand for complex, early-phase research.
20-Nov-2012 - Outsourcing-pharma.com witnessed a fascinating debate on the definition of ‘CRO’ yesterday with terms like 'collaboration' and 'release' being suggested as potential alternatives.
20-Nov-2012 - The contract sales market is set to hit $3.9bn in 2013, according to visiongain.
20-Nov-2012 - CRO Spinnovation Biologics says its cell culture optimization technique complies with analytical methods detailed in ICH Q2A and Q2B guidelines.
20-Nov-2012 - Medpace has acquired Meditech Strategic Consulting in a bid to expand its European clinical trial services.
19-Nov-2012 - More analysis suggests that collecting data for non-core endpoints costs individual sponsors millions per clinical trial and the industry billions each year.
19-Nov-2012 - CROs must swipe the lion’s share of clinical development work from Big Pharma for innovation to happen, according to a PCT panel.
|« Previous month||Next month »|